Evidence map›Paper›PMID 14585971›Full record

ArticleMolecular and cellular biology2003

Identification of HiNF-P, a key activator of cell cycle-controlled histone H4 genes at the onset of S phase.

Partha Mitra, Rong-Lin Xie, Ricardo Medina, Hayk Hovhannisyan, S Kaleem Zaidi, Yue Wei, J Wade Harper, Janet L Stein, André J van Wijnen, Gary S Stein

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Cell-cycle-regulated transcriptional pausing ofMolecular biology of the cell · 2025
    Article
  6. Cell cycle-regulated transcriptional pausing ofbioRxiv : the preprint server for biology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Premature Growth Plate Closure Caused by a Hedgehog Cancer Drug Is Preventable by Co-Administration of a Retinoid Antagonist in Mice.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2021
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Partha MitraDepartment of Cell Biology and Cancer Center, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA.
Rong-Lin Xie
Ricardo Medina
Hayk Hovhannisyan
S Kaleem Zaidi
Yue Wei
J Wade Harper
Janet L Stein
André J van Wijnen
Gary S Stein
University of Massachusetts Chan Medical School · USBaylor College of Medicine · US

Funding

IDENTIFICATION OF HUMAN HISTONE GENE REGULATORY SEQUENCER01GM032010 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STEIN, GARY S. · 1985 to 2006
$3.4M
NIGMS NIH HHS GM 32010NIGMS NIH HHS R01 GM032010
6 · The paper itself

Abstract

At the G(1)/S phase cell cycle transition, multiple histone genes are expressed to ensure that newly synthesized DNA is immediately packaged as chromatin. Here we have purified and functionally characterized the critical transcription factor HiNF-P, which is required for E2F-independent activation of the histone H4 multigene family. Using chromatin immunoprecipitation analysis and ligation-mediated PCR-assisted genomic sequencing, we show that HiNF-P interacts with conserved H4 cell cycle regulatory sequences in vivo. Antisense inhibition of HiNF-P reduces endogenous histone H4 gene expression. Furthermore, we find that HiNF-P utilizes NPAT/p220, a substrate of the cyclin E/cyclin-dependent kinase 2 (CDK2) kinase complex, as a key coactivator to enhance histone H4 gene transcription. The biological role of HiNF-P is reflected by impeded cell cycle progression into S phase upon antisense-mediated reduction of HiNF-P levels. Our results establish that HiNF-P is the ultimate link in a linear signaling pathway that is initiated with the growth factor-dependent induction of cyclin E/CDK2 kinase activity at the restriction point and culminates in the activation of histone H4 genes through HiNF-P at the G(1)/S phase transition.

Indexed as

Amino Acid SequenceBase SequenceCloning, MolecularDNA, ComplementaryGene Expression RegulationHeLa CellsHistonesHumansMolecular Sequence DataMolecular WeightRecombinant ProteinsRepressor ProteinsSignal TransductionS PhaseTranscription FactorsZinc FingersDNA, ComplementaryHINFP protein, humanHistonesRecombinant ProteinsRepressor ProteinsTranscription Factors

Identifiers

PMID14585971
PMCPMC262391
OpenAlexW2116855282

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.